CRL vs THR · rev $2.00B vs P/E 45, rev $536.3M
Charles River Laboratories (CRL) versus Thermon Group Holdings Inc (THR) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Thermon Group Holdings Inc (THR) is a specialty industrial machinery company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported THR revenue for 2026-03-31 was $536.3M. Net income was $44.6M. Revenue was up 7.6% from 2025-03-31 to 2026-03-31. THR currently screens at market cap $2.01B and trailing P/E 45.0.
CRL currently screens at market cap $7.78B. THR currently screens at market cap $2.01B and trailing P/E 45.0.
Not investment advice. Open the CRL and THR stock pages for the full models.
Not investment advice.